Whole genome analysis in APOE4 homozygotes identifies the DAB1-RELN pathway in Alzheimer’s disease pathogenesis

Bracher-Smith, Matthew, Leonenko, Ganna ORCID: https://orcid.org/0000-0001-8025-661X, Baker, Emily, Crawford, Karen, Graham, Andrew, Salih, Dervis, Howell, Brian, Hardy, John and Escott-Price, Valentina ORCID: https://orcid.org/0000-0003-1784-5483 2022. Whole genome analysis in APOE4 homozygotes identifies the DAB1-RELN pathway in Alzheimer’s disease pathogenesis. Neurobiology of Aging 119 , pp. 67-76. 10.1016/j.neurobiolaging.2022.07.009

	PDF - Supplemental Material Available under License Creative Commons Attribution. Download (773kB)
Preview	PDF - Published Version Available under License Creative Commons Attribution. Download (1MB) | Preview

Abstract

The APOE-ε4 allele is known to predispose to amyloid deposition and consequently is strongly associated with Alzheimer's disease (AD) risk. There is debate as to whether the APOE gene accounts for all genetic variation of the APOE locus. Another question which remains is whether APOE-ε4 carriers have other genetic factors influencing the progression of amyloid positive individuals to AD. We conducted a genome-wide association study in a sample of 5,390 APOE-ε4 homozygous (ε4ε4) individuals (288 cases and 5,102 controls) aged 65 or over in the UK Biobank. We found no significant associations of SNPs in the APOE locus with AD in the sample of ε4ε4 individuals. However, we identified a novel genome-wide significant locus associated to AD, mapping to DAB1 (rs112437613, OR=2.28, CI=1.73-3.01, p=5.4 × 10−9). This identification of DAB1 led us to investigate other components of the DAB1-RELN pathway for association. Analysis of the DAB1-RELN pathway indicated that the pathway itself was associated with AD, therefore suggesting an epistatic interaction between the APOE locus and the DAB1-RELN pathway.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Advanced Research Computing @ Cardiff (ARCCA) MRC Centre for Neuropsychiatric Genetics and Genomics (CNGG) Medicine
Publisher:	Elsevier
ISSN:	0197-4580
Funders:	MRC
Date of First Compliant Deposit:	2 August 2022
Date of Acceptance:	23 July 2022
Last Modified:	23 Jul 2024 15:59
URI:	https://orca.cardiff.ac.uk/id/eprint/151606

Actions (repository staff only)

Edit Item